Thursday, November 9, 2017
November 09, 2017 at 11:03PM Guidance for Industry and FDA Staff: IND Applications for Minimally Manipulated, Unrelated Allogeneic Placental/Umbilical Cord Blood Intended for Hematopoietic and Immunologic Reconstitution in Patients with Disorders Affecting the Hematopoietic System
via What's New: Vaccines, Blood & Biologics RSS Feed http://ift.tt/2iKsJbt
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment